127
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students : A Systematic Review and Meta-Analysis

      research-article
      , BA, , MPhil, , MD, , BA, BS, , MD, MPhil, , MD, MS, , MD, PhD, , MD, MPH
      JAMA

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          IMPORTANCE

          Medical students are at high risk for depression and suicidal ideation. However, the prevalence estimates of these disorders vary between studies.

          OBJECTIVE

          To estimate the prevalence of depression, depressive symptoms, and suicidal ideation in medical students.

          DATA SOURCES AND STUDY SELECTION

          Systematic search of EMBASE, ERIC, MEDLINE, psycARTICLES, and psycINFO without language restriction for studies on the prevalence of depression, depressive symptoms, or suicidal ideation in medical students published before September 17, 2016. Studies that were published in the peer-reviewed literature and used validated assessment methods were included.

          DATA EXTRACTION AND SYNTHESIS

          Information on study characteristics; prevalence of depression or depressive symptoms and suicidal ideation; and whether students who screened positive for depression sought treatment was extracted independently by 3 investigators. Estimates were pooled using random-effects meta-analysis. Differences by study-level characteristics were estimated using stratified meta-analysis and meta-regression.

          MAIN OUTCOMES AND MEASURES

          Point or period prevalence of depression, depressive symptoms, or suicidal ideation as assessed by validated questionnaire or structured interview.

          RESULTS

          Depression or depressive symptom prevalence data were extracted from 167 cross-sectional studies (n = 116 628) and 16 longitudinal studies (n = 5728) from 43 countries. All but 1 study used self-report instruments. The overall pooled crude prevalence of depression or depressive symptoms was 27.2% (37 933/122 356 individuals; 95% CI, 24.7% to 29.9%, I 2 = 98.9%). Summary prevalence estimates ranged across assessment modalities from 9.3% to 55.9%. Depressive symptom prevalence remained relatively constant over the period studied (baseline survey year range of 1982–2015; slope, 0.2% increase per year [95% CI, −0.2% to 0.7%]). In the 9 longitudinal studies that assessed depressive symptoms before and during medical school (n = 2432), the median absolute increase in symptoms was 13.5% (range, 0.6% to 35.3%). Prevalence estimates did not significantly differ between studies of only preclinical students and studies of only clinical students (23.7% [95% CI, 19.5% to 28.5%] vs 22.4% [95% CI, 17.6% to 28.2%]; P = .72). The percentage of medical students screening positive for depression who sought psychiatric treatment was 15.7% (110/954 individuals; 95% CI, 10.2% to 23.4%, I 2 = 70.1%). Suicidal ideation prevalence data were extracted from 24 cross-sectional studies (n = 21 002) from 15 countries. All but 1 study used self-report instruments. The overall pooled crude prevalence of suicidal ideation was 11.1% (2043/21 002 individuals; 95% CI, 9.0% to 13.7%, I 2 = 95.8%). Summary prevalence estimates ranged across assessment modalities from 7.4% to 24.2%.

          CONCLUSIONS AND RELEVANCE

          In this systematic review, the summary estimate of the prevalence of depression or depressive symptoms among medical students was 27.2% and that of suicidal ideation was 11.1%. Further research is needed to identify strategies for preventing and treating these disorders in this population.

          Related collections

          Author and article information

          Journal
          7501160
          5346
          JAMA
          JAMA
          JAMA
          0098-7484
          1538-3598
          18 May 2017
          06 December 2016
          26 September 2017
          : 316
          : 21
          : 2214-2236
          Affiliations
          Harvard Medical School, Boston, Massachusetts (Rotenstein, Torre, Segal, Peluso, Mata); Harvard Business School, Boston, Massachusetts (Rotenstein); Yale School of Medicine, Yale University, New Haven, Connecticut (Ramos); Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts (Torre); Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts (Peluso); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (Guille); Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor (Sen); Department of Psychiatry, University of Michigan, Ann Arbor (Sen); Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts (Mata); Brigham Education Institute, Boston, Massachusetts (Mata)
          Author notes
          Corresponding Author: Douglas A. Mata, MD, MPH, Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital, Brigham Education Institute, Harvard Medical School, 75 Francis St, Boston, MA 02115 ( dmata@ 123456bwh.harvard.edu )
          Article
          PMC5613659 PMC5613659 5613659 nihpa875825
          10.1001/jama.2016.17324
          5613659
          27923088
          b9b5fd91-3d51-46ba-aef2-77785c2aef1e
          History
          Categories
          Article

          Comments

          Comment on this article